Medtronic plc logo

Medtronic plc (MDT)

Market Closed
22 Jul, 20:00
NYSE NYSE
$
81. 89
-0.46
-0.5586%
$
106.5B Market Cap
25.14 P/E Ratio
2.84% Div Yield
4.67M Volume
5.2 Eps
$ 82.35
Previous Close
Add Transaction
Day Range
81.53 83
Year Range
73.31 106.33
Want to track MDT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices

Retirement Strategy: 2 Dividend Aristocrats At Bargain Prices

Buying battle-tested dividend aristocrats can be a winning strategy for those seeking durable retirement income. What's even better is if they also carry strong balance sheets and are attractively valued. In this article, I highlight 2 such picks, which, on a combined basis, offer immediate diversification and potential for market-beating total returns.

Seekingalpha | 1 year ago
MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?

MDT Stock Trades Cheaper Than Peers Ahead of Q3 Earnings: Time to Buy?

Medtronic expects its fiscal 2025 third-quarter revenues to reflect an unfavorable impact of 1% from currency translation.

Zacks | 1 year ago
Medtronic (MDT) Laps the Stock Market: Here's Why

Medtronic (MDT) Laps the Stock Market: Here's Why

In the closing of the recent trading day, Medtronic (MDT) stood at $91.69, denoting a +0.79% change from the preceding trading day.

Zacks | 1 year ago
Medtronic (MDT) Outperforms Broader Market: What You Need to Know

Medtronic (MDT) Outperforms Broader Market: What You Need to Know

In the most recent trading session, Medtronic (MDT) closed at $91.99, indicating a +0.63% shift from the previous trading day.

Zacks | 1 year ago
3 Reasons to Buy Medtronic Stock Like There's No Tomorrow

3 Reasons to Buy Medtronic Stock Like There's No Tomorrow

Shares of Medtronic (MDT 0.32%) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from its diabetes segment, but it appears to have finally turned the corner with its increasingly diversified operating profile.

Fool | 1 year ago
1 Top Dividend Stock to Buy in 2025, and 1 to Avoid

1 Top Dividend Stock to Buy in 2025, and 1 to Avoid

When you're buying income stocks, a company's underlying business is arguably still the most crucial factor to consider, even more than the dividend yield. Corporations with high yields may look attractive, but sometimes these are unsustainable.

Fool | 1 year ago
Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends

Here's How Many Shares of Medtronic You Need to Own to Get $1,000 in Yearly Dividends

If you're a dividend investor, I can understand why -- because dividend-paying stocks offer a triple upside: As long as the underlying company is healthy and growing, its stock price will likely increase over time. It will deliver value to shareholders via a cash distribution, as well, in the form of dividends.

Fool | 1 year ago
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know

Medtronic (MDT) closed at $90.19 in the latest trading session, marking a +1.05% move from the prior day.

Zacks | 1 year ago
Medtronic appoints Renault's exec Thierry Piéton as finance chief

Medtronic appoints Renault's exec Thierry Piéton as finance chief

Medtronic said on Monday it will appoint Renault's finance chief Thierry Piéton as its Chief Financial Officer, effective March 3.

Reuters | 1 year ago
Here's Why Medtronic (MDT) Gained But Lagged the Market Today

Here's Why Medtronic (MDT) Gained But Lagged the Market Today

Medtronic (MDT) concluded the recent trading session at $85.40, signifying a +0.18% move from its prior day's close.

Zacks | 1 year ago
Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Medtronic plc (MDT) 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Medtronic plc (NYSE:MDT ) 43rd Annual J.P. Morgan Healthcare Conference Call January 13, 2025 5:15 PM ET Company Participants Geoff Martha - Chief Executive Officer Sean Salmon - EVP & President, Cardiovascular Portfolio Gary Corona - Interim Chief Financial Officer Que Dallara - EVP & President, Diabetes Operating Unit Conference Call Participants Robbie Marcus - JPMorgan Robbie Marcus Good afternoon, everyone.

Seekingalpha | 1 year ago
2 MedTech Stocks That Are Screaming Buys in January

2 MedTech Stocks That Are Screaming Buys in January

At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient care and health outcomes. Industry leaders are well-positioned to deliver shareholder value by addressing the growing healthcare demands of an aging global population and the rising prevalence of chronic diseases.

Fool | 1 year ago
Loading...
Load More